Repurposing Valsartan May Protect Against Pulmonary Hypertension
Conditions: Pulmonary Arterial Hypertension; Right Heart Failure; Right Ventricular Dysfunction; Pulmonary Vascular Disorder Interventions: Drug: Valsartan 40 mg; Drug: Placebo Sponsors: University of Washington; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials